Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials
Article in Expert Opinion on Investigational Drugs (February 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Expert Opinion on Investigational Drugs (February 2024)
Article in Journal of Translational Medicine (January 2024)